Peptide Therapeutics Forum @ Basel Life, 11.-12.09.19
Congress Center Basel, 10 - 11 September 2019
Chairs
Thomas Vorherr (Novartis Pharma AG, Basel, Switzerland)
Roderich Süssmuth (Technical University of Berlin, Germany)
Tuesday, 10 September 2019
| 10.00 | Playmolecule, a repository of deep learning based applications for biomolecule design Franck Chevalier (Acellera, Barcelona, Spain) |
| 10.30 | Optimization of the lipopeptide arylomycin natural product into Gram-negative antibiotics Christopher Heise (Genentech Research & Early Development, San Francisco, United States) |
| 11.00 | Break |
| 11.30 | Activation of the Hippo pathway via targeting of transcription factor TEAD using designed tertiary protein structure mimetics Helene Adihou (Astra Zeneca, Dortmund, Germany) |
| 12.00 | Elimination of Aβ oligomers by the orally available all-D-peptide PRI-002 reverses cognition deficits and decelerates neurodegeneration Dieter Willbold (University of Düsseldorf, Germany) |
| 12.30 | Lunch break and Industry Symposium |
| 14.00 | PLENARY LECTURE The chemical evolution of endocrine hormones Richard DiMarchi (University of Indiana, Bloomington, United States) |
| 15.00 | Break |
| 15.30 | Peptide platforms for therapy and imaging: The first total synthesis of amanitin for ADCs and one-step 18F-labeling PET-oncology David Perrin (University of British Columbia, Vancouver, Canada) |
| 16.00 | Virobiome derived anti-inflammatory short peptides Michael Ruff (Creative BioPeptides) |
Wednesday, 11 September 2019
| 10.00 | Exotic side chain-to-side-chain cyclization modes in octreotide analogs for tumor pretargeting Anna Maria Papini (University of Florence, Italy) |
| 10.30 | Peptide-based radiopharmaceuticals for cancer imaging and therapy Agonist or Antagonist? Does it really matter? Melpomeni Fani (University Hospital Basel, Switzerland) |
| 11.00 | Break |
| 11.30 | Vancomycin regains effectiveness for resistant bacteria by conjugation to cationic peptides Walter Mier (University of Heidelberg, Germany) |
| 12.00 | Peptide discovery at protagonist therapeutics: A platform yielding multiple clinical candidates Mark Smythe (Protagonist, Newark, United States) |
| 12.30 | Lunch break and Industry Symposium |
| 14.00 | Disulfide-rich peptide production Mike Pennington (AmbioPharm, North Augusta, United States) |
| 14.30 | A new green solvent for solid phase peptide synthesis Jon Collins (CEM, Matthews, United States) |
| 15.00 | Break |
| 15.30 | Synthetic immune system engagers target cancer cells and prevent tumor formation Christian Becker (University of Vienna, Austria) |
| 16.00 | Discovery and clinical development of an inhaled cyclic peptide elastase inhibitor for the treatment of cystic fibrosis Roxana Drake & Marc Thommen (Santhera Pharmaceuticals CH Ltd., Pratteln, Switzerland) |
The programme indicated maybe subject to change!
Website Basel Life: https://www.basellife.org/
David Spichiger, SCS
17.04.2019
10% discount on registration fees for the 2nd Molecules Medicinal Chemistry Symposium (MMCS), Barcelona, 15–17 May 2019
As part of its partnership with MDPI, SCS offers 10% discount on registration fees for the "2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery", to be held in Barcelona, Spain, 15–17 May 2019.
This event will bring together leading researchers from around the world to share their recent findings on a range of topics related to the medicinal chemistry of particularly challenging diseases, as well as novel and revisited drug discovery approaches. The conference chairs are Diego Muñoz-Torrero and F. Javier Luque from the university of Barcelona. You can find more information at https://mmcs2019.sciforum.net/.
While registering to the conference, please enter the SCS discount code:
Get the SCS-MDPI discount code (visible after the member login process only).
Discount on OA publications
As a SCS member you profit also from the following benefits:
 |
20% discount for publications in Molecules mdpi.com/journal/molecules |
 |
10% discount for publications in Catalysts mdpi.com/journal/catalysts |
 |
10% discount for publications in Polymers mdpi.com/journal/polymers |
 |
10% discount for publications in Pharmaceuticals mdpi.com/journal/pharmaceuticals |
When handing in your manuscript, please enter the SCS discount code.
Get the SCS-MDPI discount code (visible after the member login process only).
Conference Support and CHIMIA endowment
Beside granting discounts on OA publishing fees, MDPI also supported SCS conferences in 2018 as partner and sponsor and took over the endowment for CHIMIA issue 5/2018.
| * |
About MDPIMDPI (Multidisciplinary Digital Publishing Institute) is an academic open-access publisher with headquarters in Basel, Switzerland. Additional offices are located in Beijing and Wuhan (China), Barcelona (Spain) as well as in Belgrade (Serbia). MDPI publishes 188 diverse peer-reviewed, scientific, open access, electronic journals. Our publishing activities are supported by more than 15,700 active scientists and academic editors on our journals' international editorial boards, including several Nobelists. More than 263,500 individual authors have already published with MDPI. MDPI.com receives more than 8.4 million monthly webpage views.
|
* |
|
|
David Spichiger, SCS
04.12.2018
Friedrich-Miescher-Award 2019: Call for applications!
To commemorate the 100-year anniversary of the discovery of nucleic acids, the MCB section of LS2 (formerly Swiss Society for Molecular and Cellular Biosciences/Swiss Society for Biochemistry) has created the Friedrich-Miescher-Award. The prize is intended to honour young biochemists and is donated by the Friedrich-Miescher-Institute in Basel.
Please feel encouraged to nominate candidates for the award. The guidelines for applications are listed below.
The submission deadline is November 1st, 2018.
Please follow the guidelines below.
Application guidelines
- The Friedrich-Miescher-Award may be awarded once every year to a young scientist for outstanding achievements in biochemistry.
- Candidates are eligible who have not yet reached the age of 40 years (for women with children 42) on January 1st of the award year.
- Preference will be given to candidates with a documented record of independent research.
- The scientific work must have been carried out in Switzerland or by Swiss scientists abroad.
Applications or nominations, including a letter stating the relevance of the candidate's scientific work, his/her CV, list of publications, and embedded links to the four most relevant publications should be submitted by November 1st, 2018 by e-mail as a single PDF file to the secretary of the Molecular and Cellular Biosciences section of LS2: Prof. Dr. Anne Spang, Biozentrum, University of Basel,
Award Ceremony
The Award ceremony will take place on the February 14th, 2019, at the LS2 Annual Meeting 2019, University of Zurich, Irchel Campus.
David Spichiger, SCS
16.10.2018
Save the date: LS2 Annual Meeting 2019, February 14-15, 2019
LS2 Annual Meeting 2019: “Cell Biology from Tissue to Nucleus”
14-15 February 2019
University of Zurich, Irchel Campus
www.annual-meeting.ls2.ch
Meeting Information & Highlights:
Meeting chair: Monica Gotta (UNIGE)
Scientific Committee: Vikram Panse (UZH), Darren Gilmour (UZH), Anne Spang (UNIBAS), Peter Meister (UNIBE), Suliana Manley (EPFL)
Plenary speakers:
- Anna Akhmanova, Utrecht University (NL)
- Anne Bertolotti, Cambridge (UK)
- Jody Rosenblatt, University of Utah (US)
- Leonie Ringrose, Berlin (DE)
Scientific Symposia:
3D Proteomics - Live-cell imaging approaches in Cell Biology - Regeneration and pathology of skeletal muscle - Chromatin, epigenetics and the transmission of acquired states across generation - Bacterial Cell Biology - Chemical Biology & Drug Development - Sweet molecules in inflammation and cancer: Novel insights and therapeutic options offered by glycosciences
Special Sessions:
PI’s of Tomorrow (First time as a plenary session, all infos & call for applications on: https://annual-meeting.ls2.ch/pis-of-tomorrow) - Public Panel on “Is merit (gender) biased? Advancement in Academia” chaired by Gerlind Wallon (EMBO Deputy Director & Program Manager) - Careers Lunch Session for students & Postdocs
…plus 2 dedicated poster sessions, Jubilee Apéro “50 years of LS2/USGEB”, industry exhibition with lottery, awards & more!
All further information on: www.annual-meeting.ls2.ch
Registration will open on 1 September 2018 on:www.annual-meeting.ls2.ch.
The first 20 BSc/MSc to register will get 50 CHF to support their travel arrangements!
David Spichiger, SCS
15.08.2018
Swiss Course on Medicinal Chemistry, Leysin, October 7-12, 2018
This five-day Medicinal Chemistry School that is organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society will focus on most modern aspects associated with small molecule drug discovery, highlighting the methodologies and technologies supporting hit generation, lead finding and lead optimization campaigns.
Visit the website: https://scmc18.chemistrycongresses.ch/en/
In the beautiful and scenic village of Leysin, close to Lake Geneva, more than 100 young scientists are expected to meet with app. 35 international renowned expert speakers and instructors.
As in previous years, the teaching content will be targeted at young scientists working in the area of medicinal chemistry, but also from flanking disciplines such as biochemistry, pharmacy, pharmacology, or biophysics from the pharmaceutical and biotech industry. Given the broad spectrum and the timeliness of scientific topics discussed, the course also provides a valuable opportunity for advanced medicinal chemists to get acquainted with most recent developments in e.g. the medicinal chemistry of novel target families, novel compound classes, and most modern optimization paradigms. In addition, a number of PhD students and postdocs will be able to attend to receive a broad overview on scientific disciplines involved in modern drug discovery.
The upcoming event will thematically be structured along key topics of strategic relevance for medicinal chemistry that will be presented by opinion leaders in the field. The teaching content will further be intensified by hands-on tutorials in which the theoretical learning’s can immediately be applied to real life problems of pre-clinical drug discovery.
Experts:
- Dr. Karin Briner, Vice President and Global Head of Discovery Chemistry at the Novartis Institute for BioMedical Research
- Dr. Nicholas A. Meanwell, Executive Director at Bristol-Myers Squibb
- Dr. Peter Grootenhuis, Senior Director at Vertex Pharmaceuticals
- Prof. Dr. Gerhard Klebe, Univeristy of Marburg
- Dr. Jonathan Mason, Drug Design and Computational Chemistry Expert at Heptares Therapeutics
- Dr. Andy Phillips, Chief Scientific Officer and President at C4 Therapeutics
David Spichiger, SCS
29.01.2018
Page 269 of 298